Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis.

Neurol Neuroimmunol Neuroinflamm · 2023 · PMC9773420 · PMID 36543540

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

did not reach statistical significancep = 0.061so close (0.05 < p ≤ 0.1)

After separately analyzing MS types and adjusting for the effect of BMI, disease duration, and DMT use, the difference in sNfL levels between patients with RRMS and SPMS remained significant ( p = 0.046); sGFAP was higher in patients with SPMS compared with patients with RRMS but did not reach statistical significance ( p = 0.061).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.